Apellis Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (20 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 4,681 | 0.0% | 186,328 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 3,308 | 0.0% | 146,188 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 2,331 | 0.0% | 134,637 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 2,771 | 0.0% | 126,706 | 3/31/2025 |
| 2024 Q4 | 4/23/2025 | 4,042 | 0.0% | 126,659 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 3,968 | 0.0% | 137,594 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 6,658 | 0.0% | 173,574 | 6/30/2024 |
| 2024 Q1 | 4/30/2024 | 8,572 | 0.0% | 145,833 | 3/31/2024 |
| 2023 Q4 | 2/1/2024 | 8,730 | 0.0% | 145,833 | 12/31/2023 |
| 2023 Q3 | 11/2/2023 | 6,993 | 0.0% | 183,844 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 16,597 | 0.0% | 182,188 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 9,367 | 0.0% | 142,006 | 3/31/2023 |
| 2022 Q4 | 2/8/2023 | 9,926 | 0.0% | 191,964 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 11,589 | 0.0% | 169,682 | 9/30/2022 |
| 2021 Q1 | 5/14/2021 | 5,250 | 0.0% | 122,358 | 3/31/2021 |
| 2020 Q4 | 2/2/2021 | 8,007 | 0.0% | 139,978 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 4,113 | 0.0% | 136,334 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 4,338 | 0.0% | 132,834 | 6/30/2020 |
| 2020 Q1 | 5/12/2020 | 3,408 | 0.0% | 127,212 | 3/31/2020 |
| 2019 Q4 | 1/27/2020 | 3,365 | 0.0% | 109,899 | 12/31/2019 |